In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.
Making B2B Creative Edgy
Andy Pharoah on Mars and sustainability
How Mentoring Empowers Women In PR
The benefits of being a B-Corp
PR & The Facebook Whistleblower
Making Impact: Strategy, Shared Values, And Purpose (Part 2)
John Brown on COP27 and climate crisis communications
Making Impact: Pairing Strategy And Shared Values For Purpose That Matters, Part 1
As Venture Capital And Fintech Slow, Could This Be Greentech’s Moment?
Is there a Right Decision in the Return to Office Debate?
Preparing Communicators and Leaders for Uncharted Days Ahead
How communications can help fragmented health systems
Politics & Business: Electing When to Take A Stand
APACD Podcast: Stephen Forshaw from Airbus
A Continued Conversation on a Company’s Purpose — in Light of a Potential Economic Downturn
Future PR trends — authorship, altruism & more
Engaging Your Stakeholders on Today’s Social Issues
Cannes Series: Ogilvy on the creative earned media mindset
The Gen Z Effect on the Workplace
Unique Considerations Agencies Face When Going Global
Create your
podcast in
minutes
It is Free
Making Bank
Bank of America Treasury Insights
How I Crushed It
The Ramsey Show
Planet Money